JP2004520266A5 - - Google Patents

Download PDF

Info

Publication number
JP2004520266A5
JP2004520266A5 JP2002517050A JP2002517050A JP2004520266A5 JP 2004520266 A5 JP2004520266 A5 JP 2004520266A5 JP 2002517050 A JP2002517050 A JP 2002517050A JP 2002517050 A JP2002517050 A JP 2002517050A JP 2004520266 A5 JP2004520266 A5 JP 2004520266A5
Authority
JP
Japan
Prior art keywords
bone
disease
subject
scan
liposomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002517050A
Other languages
English (en)
Japanese (ja)
Other versions
JP4217068B2 (ja
JP2004520266A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/024716 external-priority patent/WO2002011713A2/en
Publication of JP2004520266A publication Critical patent/JP2004520266A/ja
Publication of JP2004520266A5 publication Critical patent/JP2004520266A5/ja
Application granted granted Critical
Publication of JP4217068B2 publication Critical patent/JP4217068B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002517050A 2000-08-07 2001-08-06 エンドセリンアンタゴニストを用いる癌及び癌関連痛の治療方法 Expired - Fee Related JP4217068B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63338900A 2000-08-07 2000-08-07
PCT/US2001/024716 WO2002011713A2 (en) 2000-08-07 2001-08-06 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2006302713A Division JP2007084564A (ja) 2000-08-07 2006-11-08 エンドセリンアンタゴニストを用いる癌及び癌関連痛の治療方法
JP2006302712A Division JP2007063288A (ja) 2000-08-07 2006-11-08 エンドセリンアンタゴニストを用いる癌及び癌関連痛の治療方法

Publications (3)

Publication Number Publication Date
JP2004520266A JP2004520266A (ja) 2004-07-08
JP2004520266A5 true JP2004520266A5 (https=) 2007-01-11
JP4217068B2 JP4217068B2 (ja) 2009-01-28

Family

ID=24539436

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002517050A Expired - Fee Related JP4217068B2 (ja) 2000-08-07 2001-08-06 エンドセリンアンタゴニストを用いる癌及び癌関連痛の治療方法
JP2006302713A Pending JP2007084564A (ja) 2000-08-07 2006-11-08 エンドセリンアンタゴニストを用いる癌及び癌関連痛の治療方法
JP2006302712A Pending JP2007063288A (ja) 2000-08-07 2006-11-08 エンドセリンアンタゴニストを用いる癌及び癌関連痛の治療方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2006302713A Pending JP2007084564A (ja) 2000-08-07 2006-11-08 エンドセリンアンタゴニストを用いる癌及び癌関連痛の治療方法
JP2006302712A Pending JP2007063288A (ja) 2000-08-07 2006-11-08 エンドセリンアンタゴニストを用いる癌及び癌関連痛の治療方法

Country Status (22)

Country Link
EP (1) EP1347751B1 (https=)
JP (3) JP4217068B2 (https=)
KR (1) KR20030027007A (https=)
CN (1) CN1635878A (https=)
AR (1) AR031122A1 (https=)
AT (1) ATE465728T1 (https=)
AU (2) AU8113401A (https=)
BG (1) BG107577A (https=)
BR (1) BR0108865A (https=)
CA (1) CA2416879C (https=)
DE (1) DE60141979D1 (https=)
HU (1) HUP0302977A2 (https=)
IL (1) IL153769A0 (https=)
MX (1) MXPA03000984A (https=)
NO (1) NO20030593D0 (https=)
NZ (1) NZ523562A (https=)
PE (1) PE20020273A1 (https=)
PL (1) PL366160A1 (https=)
SK (1) SK1782003A3 (https=)
TW (1) TWI306760B (https=)
WO (1) WO2002011713A2 (https=)
ZA (1) ZA200300253B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219660D0 (en) 2002-08-23 2002-10-02 Astrazeneca Ab Therapeutic use
GB0403744D0 (en) 2004-02-20 2004-03-24 Astrazeneca Ab Chemical process
JP5070051B2 (ja) * 2004-06-07 2012-11-07 クー バイオロジックス インク． 癌を治療するための細菌組成物
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
EP2545920A1 (en) 2007-08-22 2013-01-16 Abbott GmbH & Co. KG Therapy for complications of diabetes
WO2011114103A1 (en) 2010-03-18 2011-09-22 Biolipox Ab Pyrimidinones for use as medicaments
NZ702796A (en) 2010-07-26 2017-03-31 Qu Biologics Inc Immunogenic anti-inflammatory compositions
CN102485238A (zh) * 2010-12-06 2012-06-06 陈炯华 芎芷镇痛方
JP6632607B2 (ja) 2014-05-02 2020-01-22 クー バイオロジックス インク．Ｑｕ Ｂｉｏｌｏｇｉｃｓ Ｉｎｃ． 抗微生物免疫修飾

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
ES2259803T3 (es) * 1996-02-13 2006-10-16 Abbott Laboratories Nuevos derivados de pirrolidina sustituidos con benzo-1,3-dioxolilo y benzofuranilo como antagonistas de endostelina.
NZ502395A (en) 1997-08-04 2002-08-28 Abbott Lab 4-Benzodioxolyl substituted pyrrolidine-3-carboxylic acid derivatives useful as endothelin antagonists
AU4382499A (en) * 1998-12-11 2000-07-03 Mactapes Limited Curtain heading tape manufacture
US6545048B1 (en) * 1999-06-29 2003-04-08 California Institute Of Technology Compositions and methods of treating cancer using compositions comprising an inhibitor or endothelin receptor activity

Similar Documents

Publication Publication Date Title
Fossåu et al. Recombinant interferon alfa‐2a with or without vinblastine in metastatic renal cell carcinoma
Lane et al. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.
Cebe et al. The effects of different restorative materials on the detection of approximal caries in cone-beam computed tomography scans with and without metal artifact reduction mode
JPH0840911A (ja) 骨損失を抑制するための併用療法
Hildebolt et al. The pattern of alveolar crest height change in healthy postmenopausal women after 3 years of hormone/estrogen replacement therapy
JP2004520266A5 (https=)
Noffke et al. Radiopacities in soft tissue on dental radiographs: diagnostic considerations: clinical review
ES2774773T3 (es) Agente terapéutico para la osteoporosis
Poulson et al. Necrotizing sialometaplasia obscuring an underlying malignancy: report of a case
JP4217068B2 (ja) エンドセリンアンタゴニストを用いる癌及び癌関連痛の治療方法
Lurie et al. Radionuclide bone imaging in the surgical treatment planning of odontogenic keratocysts
Svedha et al. Comparison of bone mineral density among pre-and post-menopausal women with and without chronic generalized periodontitis
Gourgiotis et al. Total parathyroidectomy with autotransplantation in patients with renal hyperparathyroidism: indications and surgical approach
Khetarpal et al. Radiological assessment of periapical healing using the cone beam computed tomography periapical index: case report
Koka et al. Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
JP2001505188A (ja) Ｎ―Ｌ―α―アスパルチル―Ｌ―フェニルアラニン１―メチルエステル及びその誘導体の疾患後退への使用
Ko et al. Radiographic diagnosis of systemic diseases manifested in jaws
Moinuddin et al. Acute blastomycosis thyroiditis
Hsu et al. Hyperprolactinemia associated with empty sella syndrome
Carnelio et al. Metastatic osteosarcoma to the maxilla: a case report and a review of the literature.
Xavier et al. Clinical, microscopic and imaging findings associated to McCune-Albright syndrome: Report of two cases
Carter et al. Diagnostic dilemma involving calcification in the parapharyngeal space: metastatic thyroid carcinoma masquerading as a deep lobe parotid mass
Schapira et al. Successful pamidronate treatment of severe and refractory regional migratory osteoporosis
Aslan et al. An indolent course of multiple myeloma mimicking a solitary thyroid cartilage plasmacytoma
Matsubara et al. Gorham-Stout disease: Progressive massive osteolysis of the mandible